Ubiquitination of β-Catenin by IKKβ
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : University of Kentucky, Memorial Sloan Kettering Cancer Center, University of Iowa
Protocol cited in 1 other protocol
Variable analysis
- Treatment with PS-341 (100 nM for 4 h)
- Ubiquitination of β-catenin
- Cell lines: Control 3T3-L1 cells and shIKKβ 3T3-L1 cells
- Antibodies: Anti-IKKβ, anti-IKKα, anti-Smurf2, anti-Histone H3, anti–β-catenin, anti–β-actin, anti-GAPDH, and anti-ubiquitin
- Protein isolation and quantification: RIPA buffer with protease inhibitors, BCA protein assay
- Immunoprecipitation conditions: Overnight incubation with anti–β-catenin antibody, 5 h incubation with Protein A Agarose beads
- Positive control: Not explicitly mentioned
- Negative control: Control 3T3-L1 cells (without shIKKβ treatment)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!